Acta Scientific Women's Health (ASWH)(ISSN: 2582-3205)

Review Article Volume 3 Issue 10

The Efficacy and Safety of Oral Tranexamic Acid (TXA) in the Treatment of Melasma

Mohammed Al Abadie*, Hussain Tukmatchy, Daniel Adam and Lamis Sharaf El Din

National Health Service (NHS) Community Dermatology Clinics (Health Harmonie), United Kingdom

*Corresponding Author: Mohamed Al Abadie, National Health Service (NHS) Community Dermatology Clinics (Health Harmonie), United Kingdom.

Received: August 24, 2021; Published: September 29, 2021



Melasma is a disfiguring skin disease that is often challenging to treat. Treatments options including topical remedies, laser therapies and systemic medications vary widely in efficacy and tend to display safety concerns. Systemic tranexamic acid has been widely feared in practice as a treatment option, despite growing evidence in literature of its high efficacy and safety in the management of melasma. In this article, we discuss the efficacy and safety of oral tranexamic acid in the treatment of melasma.

Keywords: Melasma; Chloasma; Tranexamic Acid; Hydroquinone; Tretinoin



  1. Passeron T and Picardo M. “Melasma, a photoaging disorder”. Pigment Cell and Melanoma Research4 (2018): 461-465.
  2. McKesey J., et al. “Melasma Treatment: An Evidence-Based Review”. American Journal of Clinical Dermatology 2 (2019): 173-225.
  3. Kwon S., et al. “Melasma: Updates and perspectives”. Experimental Dermatology6 (2018): 704-708.
  4. Gupta A., et al. “The treatment of melasma: A review of clinical trials”. Journal of the American Academy of Dermatology6 (2006): 1048-1065.
  5. Dunn C and Goa K. “Tranexamic Acid”. Drugs6 (1999): 1005-1032.
  6. Sheu S. “Treatment of melasma using tranexamic acid: what's known and what's next”. Cutis 2 (2018): E7-E8.
  7. Na J., et al. “Effect of tranexamic acid on melasma: a clinical trial with histological evaluation”. Journal of the European Academy of Dermatology and Venereology8 (2012): 1035-1039.
  8. Meaidi A., et al. “Oral tranexamic acid and thrombosis risk in women”. EClinicalMedicine (2021): 100882.
  9. Zhang L., et al. “Tranexamic Acid for Adults with Melasma: A Systematic Review and Meta-Analysis”. BioMed Research International (2018): 1-13.
  10. Lee H., et al. “Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis”. Journal of the American Academy of Dermatology 2 (2016): 385-392.
  11. Bala H., et al. “Oral Tranexamic Acid for the Treatment of Melasma: A Review”. Dermatologic Surgery6 (2018): 814-825.
  12. Kaur A., et al. “Tranexamic acid in melasma: a review”. com (2021).
  13. Tranexamic Acid 500 mg film coated tablets - Summary of Product Characteristics (SmPC) - (emc) (2021).


Citation: Mohammed Al Abadie., et al. “The Efficacy and Safety of Oral Tranexamic Acid (TXA) in the Treatment of Melasma”. Acta Scientific Women's Health 3.10 (2021):.


Acceptance rate35%
Acceptance to publication20-30 days

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 20, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US